194 related articles for article (PubMed ID: 37932447)
1. PD-1 signaling negatively regulates the common cytokine receptor γ chain via MARCH5-mediated ubiquitination and degradation to suppress anti-tumor immunity.
Liu R; Zeng LW; Li HF; Shi JG; Zhong B; Shu HB; Li S
Cell Res; 2023 Dec; 33(12):923-939. PubMed ID: 37932447
[TBL] [Abstract][Full Text] [Related]
2. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
3. E3 ubiquitin ligase RNF128 negatively regulates the IL-3/STAT5 signaling pathway by facilitating K27-linked polyubiquitination of IL-3Rα.
Yu J; Li J; Shen A; Liu Z; He TS
Cell Commun Signal; 2024 May; 22(1):254. PubMed ID: 38702781
[TBL] [Abstract][Full Text] [Related]
4. PD-1 blockade combined with IL-33 enhances the antitumor immune response in a type-1 lymphocyte-mediated manner.
He H; Shi L; Meng D; Zhou H; Ma J; Wu Y; Wu Y; Gu Y; Xie W; Zhang J; Zhu Y
Cancer Treat Res Commun; 2021; 28():100379. PubMed ID: 33951555
[TBL] [Abstract][Full Text] [Related]
5. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract][Full Text] [Related]
6. Soluble γc receptor attenuates anti-tumor responses of CD8
Kim G; Hwang H; Jo Y; Lee B; Lee YH; Kim CH; Hong C
Int J Cancer; 2018 Sep; 143(5):1212-1223. PubMed ID: 29577276
[TBL] [Abstract][Full Text] [Related]
7. PD-1 combination therapy with IL-2 modifies CD8
Hashimoto M; Araki K; Cardenas MA; Li P; Jadhav RR; Kissick HT; Hudson WH; McGuire DJ; Obeng RC; Wieland A; Lee J; McManus DT; Ross JL; Im SJ; Lee J; Lin JX; Hu B; West EE; Scharer CD; Freeman GJ; Sharpe AH; Ramalingam SS; Pellerin A; Teichgräber V; Greenleaf WJ; Klein C; Goronzy JJ; Umaña P; Leonard WJ; Smith KA; Ahmed R
Nature; 2022 Oct; 610(7930):173-181. PubMed ID: 36171288
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial E3 ubiquitin ligase MARCH5 controls mitochondrial fission and cell sensitivity to stress-induced apoptosis through regulation of MiD49 protein.
Xu S; Cherok E; Das S; Li S; Roelofs BA; Ge SX; Polster BM; Boyman L; Lederer WJ; Wang C; Karbowski M
Mol Biol Cell; 2016 Jan; 27(2):349-59. PubMed ID: 26564796
[TBL] [Abstract][Full Text] [Related]
9. MARCH5-dependent NLRP3 ubiquitination is required for mitochondrial NLRP3-NEK7 complex formation and NLRP3 inflammasome activation.
Park YJ; Dodantenna N; Kim Y; Kim TH; Lee HS; Yoo YS; Heo J; Lee JH; Kwon MH; Kang HC; Lee JS; Cho H
EMBO J; 2023 Oct; 42(19):e113481. PubMed ID: 37575012
[TBL] [Abstract][Full Text] [Related]
10. PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8
Buchan SL; Fallatah M; Thirdborough SM; Taraban VY; Rogel A; Thomas LJ; Penfold CA; He LZ; Curran MA; Keler T; Al-Shamkhani A
Clin Cancer Res; 2018 May; 24(10):2383-2394. PubMed ID: 29514845
[No Abstract] [Full Text] [Related]
11. Dual targeting of RIG-I and MAVS by MARCH5 mitochondria ubiquitin ligase in innate immunity.
Park YJ; Oanh NTK; Heo J; Kim SG; Lee HS; Lee H; Lee JH; Kang HC; Lim W; Yoo YS; Cho H
Cell Signal; 2020 Mar; 67():109520. PubMed ID: 31881323
[TBL] [Abstract][Full Text] [Related]
12. Novel regulatory roles of Mff and Drp1 in E3 ubiquitin ligase MARCH5-dependent degradation of MiD49 and Mcl1 and control of mitochondrial dynamics.
Cherok E; Xu S; Li S; Das S; Meltzer WA; Zalzman M; Wang C; Karbowski M
Mol Biol Cell; 2017 Feb; 28(3):396-410. PubMed ID: 27932492
[TBL] [Abstract][Full Text] [Related]
13. USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy.
Xiong W; Gao X; Zhang T; Jiang B; Hu MM; Bu X; Gao Y; Zhang LZ; Xiao BL; He C; Sun Y; Li H; Shi J; Xiao X; Xiang B; Xie C; Chen G; Zhang H; Wei W; Freeman GJ; Shu HB; Wang H; Zhang J
Nat Commun; 2022 Mar; 13(1):1700. PubMed ID: 35361799
[TBL] [Abstract][Full Text] [Related]
14. Augmented Antitumor Effect of Unripe
Lee EJ; Yang JH; Choi JG; Chung HS
Cells; 2022 Sep; 11(18):. PubMed ID: 36139451
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.
Apriamashvili G; Vredevoogd DW; Krijgsman O; Bleijerveld OB; Ligtenberg MA; de Bruijn B; Boshuizen J; Traets JJH; D'Empaire Altimari D; van Vliet A; Lin CP; Visser NL; Londino JD; Sanchez-Hodge R; Oswalt LE; Altinok S; Schisler JC; Altelaar M; Peeper DS
Nat Commun; 2022 Apr; 13(1):1923. PubMed ID: 35395848
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial E3 ligase March5 maintains stemness of mouse ES cells via suppression of ERK signalling.
Gu H; Li Q; Huang S; Lu W; Cheng F; Gao P; Wang C; Miao L; Mei Y; Wu M
Nat Commun; 2015 Jun; 6():7112. PubMed ID: 26033541
[TBL] [Abstract][Full Text] [Related]
17. UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity.
He C; Xing X; Chen HY; Gao M; Shi J; Xiang B; Xiao X; Sun Y; Yu H; Xu G; Yao Y; Xie Z; Xing Y; Budiarto BR; Chen SY; Gao Y; Lee YR; Zhang J
Mol Cell; 2024 Mar; 84(6):1120-1138.e8. PubMed ID: 38377992
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy.
Chen Z; Liu L; Cheng Q; Li Y; Wu H; Zhang W; Wang Y; Sehgal SA; Siraj S; Wang X; Wang J; Zhu Y; Chen Q
EMBO Rep; 2017 Mar; 18(3):495-509. PubMed ID: 28104734
[TBL] [Abstract][Full Text] [Related]
19. The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8
Xia W; Zhang S; Duan H; Wang C; Qian S; Shen H
Med Oncol; 2022 Jan; 39(3):37. PubMed ID: 35059863
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial ubiquitin ligase MARCH5 promotes TLR7 signaling by attenuating TANK action.
Shi HX; Liu X; Wang Q; Tang PP; Liu XY; Shan YF; Wang C
PLoS Pathog; 2011 May; 7(5):e1002057. PubMed ID: 21625535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
